This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
S. Botros , H. Sayed , N. Amer , M. El-Ghannam , J. L. Bennett and T. A. Day (2005). Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. International Journal for Parasitology 35, 787–791.
A. Danso-Appiah and S. J. De Vlas (2002). Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends in Parasitology 18, 125–129.
D. De Clercq , M. Sacko , J. Vercruysse , V. vanden Bussche , A. Landouré , A. Diarra , B. Gryseels and A. Deelder (1997). Assessment of cure by detection of circulating antigens in serum and urine following schistosomiasis mass treatment in two villages of the Office du Niger, Mali. Acta Tropica 68, 339–346.
L. Chitsulo , D. Engels , A. Montresor and L. Savioli (2000). The global status of schistosomiasis and its control. Acta Tropica 77, 41–51.
M. Doenhoff , J. Modha , J. R. Lambertucci and D. J. McLaren (1991). The immune dependence of chemotherapy. Parasitology Today 7, 16–18.
D. W. Dunne , A. E. Butterworth , A. J. Fulford , H. C. Kariuki , J. G. Langley , J. H. Ouma , A. Capron , R. J. Pierce and R. F. Sturrock (1992). Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. European Journal of Immunology 22, 1483–1494.
C. M. Fitzsimmons , S. Joseph , F. M. Jones , C. M. Reimert , K. F. Hoffmann , F. Kazibwe , G. Kimani , J. K. Mwatha , J. H. Ouma , E. M. Tukahebwa , H. C. Kariuki , B. Vennervald , N. B. Kabatereine and D. W. Dunne (2004). Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E. Infection and Immunity 72, 4023–4030.
B. Gryseels , A. Mbaye , S. J. De Vlas , F. F. Stelma , F. Guisse , L. Van Lieshout , D. Faye , M. Diop , A. Ly , L. A. Tchuem-Tchuente , D. Engels and K. Polman (2001). Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Tropical Medicine and International Health 6, 864–873.
S. Joseph , F. M. Jones , K. Walter , A. J. Fulford , G. Kimani , J. K. Mwatha , T. Kamau , H. C. Kariuki , F. Kazibwe , E. Tukahebwa , N. B. Kabatereine , J. H. Ouma , B. J. Vennervald and D. W. Dunne (2004). Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel. Journal of Infectious Diseases 190, 835–842.
N. B. Kabatereine , J. Kemijumbi , J. H. Ouma , R. F. Sturrock , A. E. Butterworth , H. Madsen , N. Ornbjerg , D. W. Dunne and B. J. Vennnervald (2003). Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Transaction of the Royal Society of Tropical Medicine and Hygiene 97, 599–603.
A. I. Kahama , P. G. Kremsner , G. J. van Dam and A. M. Deelder (1998). The dynamics of a soluble egg antigen of Schistosoma haematobium in relation to egg counts, circulating anodic and cathodic antigens and pathology markers before and after chemotherapy. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 629–633.
A. I. Kahama , B. J. Vennervald , Y. Kombe , R. W. Kihara , M. Ndzovu , P. Mungai and J. H. Ouma (1999). Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the coast province of Kenya. Tropical Medicine and International Health 4, 335–340.
S. D. Lawn , S. B. Lucas and P. L. Chiodini (2003). Case report: Schistosoma mansoni infection: failure of standard treatment with praziquantel in a returned traveller. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 100–101.
P. Magnussen , E. Muchiri , P. Mungai , M. Ndzovu , J. Ouma and S. Tosha (1997). A school-based approach to control of urinary schistosomiasis and intestinal helminths infections in children in Matuga, Kenya: impact of a 2-year chemotherapy program on prevalence and intensity of infections. Tropical Medicine and International Health 2, 825–831.
F. Mutapi , T. Mduluza and A. W. Roddam (2005). Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups. Immunology Letters 96, 231–240.
E. K. N'Goran , J. Utzinger , A. N. N'Guessan , I. Muller , K. Zamble , K. L. Lohourignon , M. Traoré , B. A. Sosthene , C. Lengeler and M. Tanner (2001). Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Cote d'Ivoire. Tropical Medicine and International Health 6, 817–825.
P. A. Peters , K. S. Warren and A. A. F. Mahmoud (1976). Rapid, accurate quantification of schistosome eggs via Nuclepore filters. Journal of Parasitology 62, 154–155.
A. A. Sabah , C. Fletcher , G. Webbe and M. J. Doenhoff (1986). Schistosoma mansoni: chemotherapy of infections of different ages. Experimental Parasitology 61, 294–303.
E. Saathoff , A. Olsen , P. Magnussen , J. D. Kvalsvig , W. Becker and C. C. Appleton (2004). Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. BMC Infectious Diseases 4, 40.
J. Utzinger , E. K. N'Goran , A. N'Dri , C. Lengeler and M. Tanner (2000). Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Tropical Medicine and International Health 5, 771–778.